Clinical Trial: Understanding the Long-term Impact of COVID-19 in Adults

U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07498504) titled 'Understanding the Long-term Impact of COVID-19 in Adults' on March 23.

Brief Summary: Long COVID (LC) affects an estimated 5-10% of individuals with SARS-CoV-2 causing a persistent physical, cognitive, and functional impairment with potentially severe socioeconomic consequences. While RECOVER-Adult cycle 1 established the largest, most comprehensive U.S. adult LC cohort (14,730 participants), key questions remain about long-term disease trajectories, biological mechanisms, and late-emerging complications. RECOVER-Adult cycle 2 will follow selected participants for two years each, focusing on neurocognitive, cardiopulmonary and infe...